Darin M. Friess

Darin M. Friess

Auto-generated profile, based on publicly available information

Darin M. Friess

Department of Orthopaedics and Rehabilitation, Oregon Health and Science University, Portland, Oregon

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2018 in Journal of Orthopaedic Trauma
Verified
Journal Article
Closed access
DRDuncan C Ramsey
Duncan C Ramsey
DFDarin M. Friess
Darin M. Friess
Objectives: To evaluate the cost effectiveness of suture buttons compared with syndesmotic screws for repair of tibiofibular syndesmotic injuries. Methods: A decision tree model was constructed to describe outcomes after syndesmosis repair using suture buttons and syndesmotic screws from the perspective of a capitated health care system. Outcomes were uneventful healing, removal of symptomatic implants, deep infection, and persistent diastasis requiring revision. Weighted literature averages were used to estimate variables for a baseline model. Outcomes were measured in quality adjusted life years. Procedure and implant costs were derived from Medicare reimbursement rates and the University Health System Consortium. An incremental cost-effectiveness ratio threshold of $50,000 per quality-adjusted life years was used to evaluate cost effectiveness. Results: The baseline model did not identify suture buttons to be cost effective. Sensitivity analysis demonstrates the model to be exquisitely sensitive to small changes in reoperation rates and implant price. At median University Health System Consortium implant prices, if the removal rate for symptomatic screws is below 13.7%, then screws are cost effective. If the screw removal rate is greater than 17.5%, then a suture button is cost effective. Within this interval, detailed analysis of the model suggests that screws may be the cost-effective strategy, but that determination should be taken with caution. Conclusions: Moving away from the practice of routinely removing all syndesmotic screws has changed the financial landscape of syndesmosis repair. At their median cost, suture buttons are likely to be cost effective over screws for symptomatic screw removal rates greater than 17.5%. Cost effectiveness is sensitive to changes in implant removal rates and the number of devices used per patient. Level of Evidence: Economic Level IV. See Instructions for Authors for a complete description of levels of evidence.

18 February 2020 in Journal of Orthopaedic Trauma
Verified
Journal Article
Closed access
JPJoseph T. Patterson
Joseph T. Patterson
KIKeisuke Ishii
Keisuke Ishii
PTPaul Iii Tornetta
Paul Iii Tornetta
RLRoss Leighton
Ross Leighton
DFDarin M. Friess
Darin M. Friess
SMSaam Morshed
Saam Morshed
Objectives: To determine (1) which factors are associated with the choice to perform an open reduction and (2) by adjusting for these factors, if the choice of reduction method is associated with reoperation. Design: Retrospective cohort study with radiograph and chart review. Setting: Twelve Level 1 North American trauma centers. Patients: Two hundred thirty-four adults 18–65 years of age with an isolated, displaced, OTA/AO type 31-B2 or type 31-B3 femoral neck fracture treated with internal fixation with minimum of 6-month follow-up or reoperation. Exclusion criteria were pathologic fractures, associated femoral head or shaft fractures, and primary arthroplasty. Intervention: Open or closed reduction technique during internal fixation. Main outcome: Cox proportional hazard of reoperation adjusting for propensity score for open reduction based on injury, demographic, and medical factors. Reduction quality was assessed by 3 senior orthopaedic traumatologists as “acceptable” or “unacceptable” on AP and lateral postoperative radiographs. Results: Median follow-up was 1.5 years. One hundred six (45%) patients underwent open reduction. Reduction quality was not significantly affected by open versus closed approach (71% vs. 69% acceptable, P = 0.378). The propensity to receive an open reduction was associated with study center; younger age; male sex; no history of injection drug use, osteoporosis, or cerebrovascular disease; transcervical fracture location; posterior fracture comminution; and surgery within 12 hours. A total of 35 (33%) versus 28 (22%) reoperations occurred after open versus closed reduction (P = 0.056). Open reduction was associated with a 2.4-fold greater propensity-adjusted hazard of reoperation (95% confidence interval 1.3–4.4, P = 0.004). A total of 35 (15%) patients underwent subsequent total hip arthroplasty or hemiarthroplasty. Conclusions: Open reduction of displaced femoral neck fractures in nonelderly adults is associated with a greater hazard of reoperation without significantly improving reduction. Prospective randomized trials are indicated to confirm a causative effect of open versus closed reduction on outcomes after femoral neck fracture. Level of Evidence: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.

16 August 2022 in Journal of the American Academy of Orthopaedic Surgeons
Verified
Journal Article
Closed access
NONathan Olszewski
Nathan Olszewski
GMGivenchy Manzano
Givenchy Manzano
EWEleanor Wilson
Eleanor Wilson
NJNoah Joseph
Noah Joseph
HVHeather Vallier
Heather Vallier
PTPaul Tornetta
Paul Tornetta
Objectives: The purpose of this study was to identify the patient, injury, and treatment factors associated with infection of bicondylar plateau fractures and to evaluate whether center variation exists. Design: Retrospective review. Setting: Eighteen academic trauma centers. Patients/participants: A total of 1,287 patients with 1,297 OTA type 41-C bicondylar tibia plateau fractures who underwent open reduction and internal fixation were included. Exclusion criteria were follow-up less than 120 days, insufficient documentation, and definitive treatment only with external fixation. Intervention: Open reduction and internal fixation. Main outcome measurements: Superficial and deep infection. Results: One hundred one patients (7.8%) developed an infection. In multivariate regression analysis, diabetes (DM) (OR [odds ratio] 3.24; P ≤ 0.001), alcohol abuse (EtOH) (OR 1.8; P = 0.040), dual plating (OR 1.8; P ≤ 0.001), and temporary external fixation (OR 2.07; P = 0.013) were associated with infection. In a risk-adjusted model, we found center variation in infection rates (P = 0.030). Discussion: In a large series of patients undergoing open reduction and internal fixation of bicondylar plateau fractures, the infection rate was 7.8%. Infection was associated with DM, EtOH, combined dual plating, and temporary external fixation. Center expertise may also play a role because one center had a statistically lower rate and two trended toward higher rates after adjusting for confounders. Level of evidence: Level IV—Therapeutic retrospective cohort study.

1 April 2021 in JBJS Case Connector
Verified
Journal Article
Closed access
JAJordan Arakawa
Jordan Arakawa
EWErik Woelber
Erik Woelber
ZWZachary Working
Zachary Working
JMJames Meeker
James Meeker
DFDarin Friess
Darin Friess
Cases: Intraosseous (IO) access is an effective surrogate for intravascular access in critically ill patients. We present 2 cases of IO complications. The first patient is a 44-year-old man with deep peroneal nerve sensorimotor dysfunction due to possible missed acute compartment syndrome from improper placement of a tibial IO needle. The second patient is an immunosuppressed 69-year-old man with idiopathic factor VIII deficiency who required amputation 7 months after right tibia IO access. Conclusion: These adverse events of IO access are limited in the literature. We make recommendations to reduce these outcomes.

10 September 2025 in OTA International
Verified
Journal Article
Open access
FRFrank Rodgers
Frank Rodgers
ZWZachary M. Working
Zachary M. Working
DFDarin Friess
Darin Friess
JYJung Yoo
Jung Yoo
RKRyland Kagan
Ryland Kagan
Objective: We evaluated the associated risk of postoperative periprosthetic femur fracture after hemiarthroplasty for the treatment of femoral neck fracture based on stem fixation, cementless compared with cemented. Design: A retrospective review of patient data from the PearlDiver database from 2015 to 2020. Setting: This database is comprised of 140 million deidentified patients based on national all-claims data including Medicare, Medicaid, government and private insurance. Patients/Participants: We identified 24,468 patients with hemiarthroplasty for treatment of femoral neck fracture from 2015 to 2020. Demographic data included; age, sex, diagnosis of obesity, and Charlson Comorbidity Index. Intervention: We identified postoperative periprosthetic femur fracture as our primary outcome and stratified femoral fixation as cemented 12,777 (52.2%) or cementless 11,691 (47.8%). Main Outcome Measurements: Propensity matched analysis with odds ratios (OR) was performed to evaluate association between fixation and odds of postoperative periprosthetic femur fracture; multivariate analysis was used to adjust for demographic characteristics and comorbidities. Results: Cementless fixation was associated with increased odds of post-operative periprosthetic femur fracture (OR 3.32 [95% confidence interval (CI), 2.75–4.00]; P < 0.001). Females with cementless fixation had higher odds for post-operative periprosthetic femur fracture (OR 3.70 [95% CI, 2.94–4.76]; P < 0.001). Conclusions: We noted increased associated risk of postoperative periprosthetic femur fracture with cementless femoral fixation for hemiarthroplasty to treat femoral neck fracture, particularly in females. The risk of postoperative periprosthetic femur fracture should be considered as surgeons choose femoral fixation for hemiarthroplasty in the treatment of femoral neck fracture. Level of Evidence: Therapeutic Level III.

29 August 2025 in PLOS Medicine
Verified
Journal Article
Open access
PDF file
ZWZachary M. Working
Zachary M. Working
MCMolly Czachor
Molly Czachor
ANAnna Laura Nelson
Anna Laura Nelson
KOKelsey M. O’hAra
Kelsey M. O’hAra
KLKaralynn Lancaster
Karalynn Lancaster
OIOn behalf of the Vita-Shock Investigators
On behalf of the Vita-Shock Investigators
Background: Clinical determination of bone fracture healing remains qualitative, typically determined through the combination of plain film radiographs, clinical assessment, and patient-reported pain. Importantly, standard radiographs can only detect bone formation in the fracture site after sufficient tissue mineralization has occurred, restricting utility to the later stages of bone repair. A more rigorous method for determining fracture healing progression could significantly improve patient care. Quantitative biomarkers have gained diagnostic value in many clinical indications. Multiple bone turnover biomarkers have been successfully utilized for diagnosis and clinical management of osteoporosis. However, there remains limited evidence for the correlation and diagnostic efficacy of these biomarkers when applied to fracture repair. Methods and findings: Here we present data from a large cohort of participants without (n = 111) or with (n = 153) fracture with the primary outcome of interest our blood-based biomarker which detects the degradation product of the trimeric collagen X protein (CXM). Collagen X is a transient extracellular matrix protein synthesized by hypertrophic chondrocytes during the soft callus phase of endochondral fracture repair. Our data show that healthy patients with an age range of 21−85 years without fracture (enrolled 2018−2020) have low circulating levels of CXM (median = 563.4 pg/mL; interquartile range (IQR) [483.2, 771.1]) that do not vary independently with age (r = 0.04, p = 0.26) or sex (p = 0.42). Fracture data includes patients with an acute closed or low grade open (Gustilo type I or II) tibial or femoral shaft fracture from a secondary analysis of the VitaShock study (NCT02786498, n = 102: enrolled through the University of Maryland 2016−2019), complemented by a new prospectively enrolled observational study that recruited from the Oregon Health & Science University level 1 academic trauma center (n = 51: enrolled 2019−2023) that were followed until the patient was deemed clinically healed or until they failed to return for follow-up. We show that in serum CXM positively correlates to the bone biomarkers N-terminal propeptide of type I procollagen (P1NP, r = 0.50, p < 0.0001), C-terminal telopeptide of type I collagen (CTX, r = 0.40, p < 0.0001), and osteocalcin (r = 0.26, p = 0.0411); with a negative correlation to the obesity biomarker leptin (r = −0.31, p = 0.0138). Further, patients with early healing exhibited a peak in CXM at 6 weeks of 1,092 pg/mL (95% confidence interval (CI) [804.8, 1,379]), which was significantly higher than patients with normal healing of 630.8 pg/mL (95% CI [399.9, 861.8]; p = 0.016). We then show that we can reliably transfer this assay from serum collection through venipuncture to a dried blood spot (DBS) collected by finger prick (r = 0.75, Serum = 0.4217*DBS + 181.9, p < 0.0001). Using DBS, the prospective clinical observational study finally suggests that median time-to-peak CXM is at 25.5 days following the elimination of outliers (n = 6) using Robust Regression and Outlier Removal (ROUT, Q = 1%). This study did not find significant differences in CXM expression according to age, sex, or bone that are likely due to the main limitation of an observational study. Conclusion: This rigorous data set supports the future prospective use of the CXM biomarker collected by finger prick in interventional fracture studies and/or in observational studies requiring quantitative assessments of long-bone healing.